noscapine
Pre-clinical- Indications
- Palliative care
Company intelligence / Profile preview
Gipfel Life Sciences
Zirl, Tirol, Austriagipfellifesciences.com ↗
- Ownership
- Private
- Employees
- ~5
- Development stage
- Preclinical
01
Overview
Working on metabolomics to assess tears of GBM patients for disease stratification and developing artificial veins to prevent metastases[3]
- Therapeutic areas
- Oncology
- Modalities
- Recombinant antibodies
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
ETH FGCZOxford UniversityAIST JapanAustrian Drug Screening InstitutePrecision System Science Japan[3]
Beyond the preview
Go deeper on Gipfel Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gipfel Life Sciences.